COMP <GO>
AMRZ vs RTX // 10Y YIELD & FRED MACRO BETA
Amrize Ltd (NYSE) VS. RTX Corporation (NYSE) • 15-METRIC TALLY: AMRZ 8
— RTX 5
▲ 10Y YIELD & FRED MACRO BETA LEADER: AMRZ
LAST: $41.61 (+3.95%) • MKT CAP: $22.76B
macro-sensitivity
1.10
LAST: $199.40 (+1.82%) • MKT CAP: $269.08B
macro-sensitivity
0.92
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AMRZ VS. RTX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AMRZ | RTX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 25.70% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.30% | 7.20% | +2.10 | AMRZ | /roic <GO> |
| EV/EBITDA & P/E Valuation | 10.0x | 26.5x | -16.50 | AMRZ | /valuation <GO> |
| Free Cash Flow Yield | 6.24% | 2.95% | +3.29 | AMRZ | /fcf-yield <GO> |
| Operating Margin | 16.10% | 10.50% | +5.60 | AMRZ | /operating-margins <GO> |
| Net Profit Margin | 10.00% | 7.60% | +2.40 | AMRZ | /net-margins <GO> |
| Revenue Growth (YoY) | 0.90% | 9.70% | -8.80 | RTX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 1.33% | -1.33 | RTX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.12 | 2.73 | -0.61 | RTX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 9/9 | -3.00 | RTX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 68.0 | 60.0 | +8.00 | AMRZ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 1.10 | 0.92 | +0.18 | AMRZ | /macro-sensitivity <GO> |
| Forward P/E Multiple | 17.9x | 37.2x | -19.30 | AMRZ | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $22.76B | $269.08B | -$246.32B | RTX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AMRZ REV | RTX REV | AMRZ GROSS % | RTX GROSS % | AMRZ FCF | RTX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $11.81B | $88.60B | 25.7% | — | $1.42B | $7.94B |
| FY 2024 | $11.70B | $80.74B | 26.2% | — | $1.64B | $4.53B |
| FY 2023 | $11.68B | $68.92B | — | — | $1.51B | $4.78B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AMRZ // BETA 1.10
RTX // BETA 0.92